As of 2025-05-08, the Relative Valuation of N4 Pharma PLC (N4P.L) is (1.94) GBP. This relative valuation is based on P/E multiples. With the latest stock price at 0.43 GBP, the upside of N4 Pharma PLC based on Relative Valuation is -555.5%.
The range of the Relative Valuation is (2.05) - (2.11) GBP.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 8.6x - 15.8x | 12.2x |
| Forward P/E multiples | 15.4x - 17.7x | 16.8x |
| Fair Price | (2.05) - (2.11) | (1.94) |
| Upside | -582.3% - -595.5% | -555.5% |
| Date | P/E |
| 2025-05-06 | -3.19 |
| 2025-05-02 | -3.19 |
| 2025-05-01 | -3.23 |
| 2025-04-30 | -3.19 |
| 2025-04-29 | -3.19 |
| 2025-04-28 | -2.81 |
| 2025-04-25 | -2.81 |
| 2025-04-24 | -2.81 |
| 2025-04-23 | -3.00 |
| 2025-04-22 | -2.81 |
| 2025-04-17 | -2.81 |
| 2025-04-16 | -2.81 |
| 2025-04-15 | -2.81 |
| 2025-04-14 | -2.81 |
| 2025-04-11 | -2.81 |
| 2025-04-10 | -2.81 |
| 2025-04-09 | -2.81 |
| 2025-04-08 | -3.38 |
| 2025-04-07 | -3.19 |
| 2025-04-04 | -3.19 |
| 2025-04-03 | -3.19 |
| 2025-04-02 | -3.19 |
| 2025-04-01 | -3.19 |
| 2025-03-31 | -3.19 |
| 2025-03-28 | -3.56 |
| 2025-03-27 | -3.56 |
| 2025-03-26 | -3.56 |
| 2025-03-25 | -3.56 |
| 2025-03-24 | -3.56 |
| 2025-03-21 | -3.56 |
| 2025-03-20 | -3.45 |
| 2025-03-19 | -3.56 |
| 2025-03-18 | -3.56 |
| 2025-03-17 | -3.56 |
| 2025-03-14 | -3.56 |
| 2025-03-13 | -3.56 |
| 2025-03-12 | -3.56 |
| 2025-03-11 | -3.56 |
| 2025-03-10 | -3.75 |
| 2025-03-07 | -3.75 |
| 2025-03-06 | -3.94 |
| 2025-03-05 | -3.94 |
| 2025-03-04 | -3.94 |
| 2025-03-03 | -3.94 |
| 2025-02-28 | -3.94 |
| 2025-02-27 | -3.94 |
| 2025-02-26 | -3.94 |
| 2025-02-25 | -4.31 |
| 2025-02-24 | -4.31 |
| 2025-02-21 | -4.31 |